Steven Sell - Agilon Health President, Chief Executive Officer, Director

AGL Stock  USD 2.23  0.10  4.69%   

CEO

Steven Sell is President, Chief Executive Officer, Director of agilon health since 2020.
Age 58
Tenure 4 years
Address 6210 East US Highway 290, Austin, TX, United States, 78723
Phone562 256 3800
Webhttps://www.agilonhealth.com

Agilon Health Management Efficiency

The company has Return on Asset of (0.0984) % which means that on every $100 spent on assets, it lost $0.0984. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.43) %, meaning that it generated no profit with money invested by stockholders. Agilon Health's management efficiency ratios could be used to measure how well Agilon Health manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.17. The value of Return On Capital Employed is expected to slide to -0.32. Net Tangible Assets is expected to rise to about 1.1 B this year, although the value of Total Assets will most likely fall to about 1.3 B.
agilon health has 52.31 M in debt with debt to equity (D/E) ratio of 0.05, which may show that the company is not taking advantage of profits from borrowing. agilon health has a current ratio of 2.6, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Agilon to invest in growth at high rates of return.

Similar Executives

Found 5 records

CEO Age

Joseph ZubretskyMolina Healthcare
67
Andrew WittyUnitedHealth Group Incorporated
55
Dirk McMahonUnitedHealth Group Incorporated
64
Gail BoudreauxElevance Health
63
David WichmannUnitedHealth Group Incorporated
56
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas. Agilon Health operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 646 people. agilon health (AGL) is traded on New York Stock Exchange in USA. It is located in 6210 East US Highway 290, Austin, TX, United States, 78723 and employs 1,117 people. Agilon Health is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

agilon health Leadership Team

Elected by the shareholders, the Agilon Health's board of directors comprises two types of representatives: Agilon Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Agilon. The board's role is to monitor Agilon Health's management team and ensure that shareholders' interests are well served. Agilon Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Agilon Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Benjamin Shaker, Chief Officer
Girish Venkatachaliah, Chief Technology Officer
Bill Farry, Chief Innovation
Derek Strum, Director
Michelle Gourdine, Independent Director
Timothy Gertsch, Controller VP
Denise Zamore, Chief Secretary
Sharad Mansukani, Independent Director
Jeffrey CPA, Executive CFO
Michael Smith, Independent Director
William Wulf, Director
Mat Varghese, Chief Officer
Benjamin Kornitzer, Chief Medical and Quality Officer
Claire Mulhearn, Chief Officer
Ben Shaker, Chief Markets Officer
Joan Danieley, Chief Administrative Officer
Matthew CFA, Vice Relations
Lisa Ali, Chief Officer
Ronald Williams, Non-Executive Chairman of the Board
Lisa Dombro, Chief Experience and Innovation Officer
Ravi Sachdev, Vice Chairman of the Board
Karen Mcloughlin, Director
Priscilla Kasenchak, Chief Officer
Chris Casler, Chief Human Resource Officer
Timothy Bensley, Chief Financial Officer
Leland Thomas, Senior Relations
Clay Richards, Independent Director
Veeral Desai, Chief Strategy and Development Officer
Richard Schnall, Director
Steven Sell, President, Chief Executive Officer, Director
Theodore Halkias, Chief Business Officer

Agilon Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Agilon Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether agilon health is a strong investment it is important to analyze Agilon Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Agilon Health's future performance. For an informed investment choice regarding Agilon Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in agilon health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
11.951
Earnings Share
(0.76)
Revenue Per Share
13.717
Quarterly Revenue Growth
0.276
Return On Assets
(0.1)
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.